Abstract
Lung volume reduction surgery (LVRS) improves dyspnoea, pulmonary function, and physical performance in patients with severe pulmonary emphysema. This study investigated the impact of LVRS on health-related quality of life (HRQL) over a 2-yr period following surgery.
Thirty-nine consecutive patients were prospectively assessed before LVRS, and followed over 24 months postoperatively. The assessments included pulmonary function, dyspnoea (Medical Research Council (MRC) dyspnoea score), 6-min walking distance (6MWD) and HRQL using the Short Form 36-item questionnaire (SF-36) .
Several domains of SF-36 improved considerably over 2 yrs after surgery: Physical Functioning: 39±4 (mean±sem) versus 16±2 (p<0.01); Vitality: 51±3 versus 32±3 (p<0.01); Social Functioning: 72±4 versus 51±5 (p<0.01). Also, improvements in pulmonary function (forced expiratory volume in one second (FEV1): 27±1% predicted, residual volume (RV)/total lung capacity (TLC): 0.65±0.01), 6 MWD (274±16 m) and dyspnoea (MRC: 3.9±01) were sustained for up to 2 yrs after LVRS (FEV1 36±2% pred, RV/TLC: 0.58±0.02; 6 MWD: 342±19 m; MRC: 2.0±0.2; p<0.05).
In patients with severe emphysema, lung volume reduction surgery had positive effects on health-related quality of life and pulmonary function over 2 yrs.
This study was supported by grant no. 3200-043358; 95.1 from the Swiss National Science Fund and by a grant from the Zürich Lung League.
Chronic obstructive pulmonary disease (COPD) is a fast growing cause of morbidity and mortality in the industrialized nations. In severe forms COPD is accompanied by emphysema and has the potential to substantially impair health-related quality of life (HRQL) in an affected individual 1.
Comprehensive pulmonary rehabilitation in symptomatic patients with COPD does not alter their pulmonary function, but improves exercise tolerance and decreases dyspnoea at a given work load 2. A beneficial effect of rehabilitation on quality of life was demonstrated in several investigations 3–8.
Many groups have shown that lung volume reduction surgery (LVRS) improves dyspnoea, lung function and exercise tolerance in selected patients with advanced pulmonary emphysema 9–11, but only a few studies have reported the effects of LVRS on quality of life 12, 13. Two groups used the combination of preoperative rehabilitation and consecutive LVRS and assessed the patients with the same instruments, i.e. the Short Form 36-item questionnaire (SF-36), as in the present study 10, 14. Others followed aspects of quality of life in LVRS for up to 6 months only 11, 15–18 or 12 months 19 or reported for a longer time period, but only a small number of patients were followed for up to 18 months 12, 13.
The purpose of this study was to prospectively investigate the impact of LVRS on HRQL for up to 2 yrs and to correlate changes in HRQL parameters with dyspnoea, timed walking distance and lung function.
Methods
Thirty-nine consecutive patients (17 females), with a mean±sd age of 61±1 yrs, were studied. All were previous heavy smokers and complained about severe dyspnoea (Medical Research Council (MRC) dyspnoea score: 3.9±0.1). They had severe obstruction to airflow, considerable pulmonary hyperinflation and a limited 6-min walking distance (6MWD) as shown in table 1⇓. Patients were included from April 1996–November 1998. Capability to understand the questionnaires in the German language and a follow-up period of at least 2 yrs were required. The study population for quality of life assessment was smaller than the cohort of 83 patients who underwent bilateral LVRS by video-assisted thoracoscopy (VAT) at the Pulmonary Division, the Dept of Internal Medicine, University Hospital, Zürich from April 1996–November 2000 for the following reasons: seven patients died, nine patients were lost for follow-up, five patients underwent lung transplantation, and the remainder of the patients had insufficient comprehension of the German language (n=1) or a follow-up period of <2 yrs. Only two perioperative deaths (within 30 days of LVRS) were observed. The other patients died in the later course due to typical complications of COPD, i.e. pulmonary infection, respiratory failure, pulmonary emboli. The baseline data amongst the 39 patients with a follow-up for 2 yrs and the 33 patients with a briefer follow-up were comparable with respect to age, sex distribution, dyspnoea score, HRQL and pulmonary function except for a residual volume (RV)/total lung capacity (TLC) of 0.65 (0.01) in those with a 2-yr follow-up as compared to the rest with a RV/TLC of 0.68 (0.01) (p=0.03). The two groups also experienced comparable improvements in the various parameters at 3 months after surgery except for 6MWD, where the 2-yr study group improved by 100 m from a baseline of 273 m and the other group by 48 m from a baseline of 284 m (p=0.02).
All patients were selected for LVRS according to previously published criteria 20, 21 and gave written informed consent to a prospective study on outcome after LVRS which was approved by the hospital's ethic committee. No systematic pulmonary rehabilitation was performed pre- or postoperatively.
Patients were assessed for dyspnoea, pulmonary function, 6MWD, HRQL, chest radiographs, pulmonary computed tomography and lung perfusion scintigrams. At 3 and 6 months postoperatively and at 6-monthly intervals thereafter grading of dyspnoea, pulmonary function tests, 6MWD and HRQL were repeated.
Dyspnoea was rated according to the American Thoracic Society modified MRC dyspnoea score 22. The patient describes the degree of dyspnoea which is graded with an integer from 0–4. Zero means breathlessness only with strenuous exercise, 4 means that the patient is unable to leave the house or is breathless while dressing.
Pulmonary function tests were performed after inhalation of two puffs of salbutamol adhering to standard criteria 23, 24 with the Sensor Medics Autobox plethysmograph (Yorba Linda, CA, USA). Reference values were in accordance to the European Community for Steel and Coal 24, 25.
For assessment of the 6MWD, the patients walked attended but without oxygen supplementation along the same hospital hallway.
For the assessment of HRQL, the German version of the Medical Outcomes Study SF-36, which contains eight domains (Physical Functioning, Role Physical, Vitality, General Health, Social Functioning, Role Emotional, Mental Health, Bodily Pain), was used 26. The domain scores are rated so that higher values indicate better health (range 0–100) (see Appendix). The number of missing data was low (<5% at any individual time point) and randomly distributed with respect to various domains of HRQL.
Surgical lung volume reduction was performed bilaterally by VAT as previously described 27.
Data analysis
Data are presented as mean±sem. Unpaired t-tests for independent samples or repeated measurement analysis of variance (ANOVA) was performed, using contrast vector analysis to compare differences between specific postoperative and preoperative time points. Differences between proportions were analysed by Chi-squared tests. Univariate linear regression analysis of changes in pulmonary function and changes in the SF-36 domain “physical functioning” was performed using the Pearson method. A p-value ≤0.05 was considered as significant.
Results
As shown in table 1⇓, the patients experienced disabling shortness of breath, their timed walking distance was considerably reduced and baseline pulmonary function documented severe airflow obstruction as well as pulmonary hyperinflation. The mean oxygen tension in arterial blood was 65±1 mmHg, whereas the mean carbon dioxide tension in arterial blood was normal with 39±1 mmHg. The diffusing capacity for carbon monoxide was decreased to 42±2% predicted.
Health-related quality of life
At baseline HRQL was profoundly impaired. The lowest SF-36 scores were observed for Physical Functioning (16±2) and Role-Physical (15±5). Vitality (32±3), General Health (45±4), and Social Functioning (51±5) showed marked deficits as well, whereas the impairments were less pronounced with respect to Role Emotional (60±7) and Mental Health (66±4) (table 1⇓). Most patients did not suffer from relevant pain (Bodily Pain: 80±4). The SF-36 dimension Physical Functioning was moderately correlated with the preoperative degree of dyspnoea (r=0.34, p<0.05), and with the preoperative 6MWD (r=0.48, p<0.005). No significant correlations were found between Physical Functioning and forced expiratory volume in one second (FEV1) % pred, or the degree of hyperinflation, as assessed by the RV/TLC ratio, respectively.
The main finding was an improvement in scores of five domains of the SF-36 quality of life instrument (table 1⇓, fig. 1⇓). Marked increases were observed in the two dimensions Physical Functioning (16±2–55±4) and Role-Physical (15±56–46±7). Relevant increases were also observed in Vitality (32±3–60±3) as well as in Social Functioning (51±5–82±3). The dimension, General Health also increased (45±3–63±3; p<0.05). Mental Health, which was slightly reduced, improved to some extent, Role-Emotional tended to improve, whereas Bodily Pain remained unchanged. There were no differences between the responses of males and females. There was no correlation between the duration of hospital stay or perioperative morbidity with the subsequent health status in the patients.
The time course for the various HRLQ dimensions are shown in table 1⇓ and figure 1⇓. Beneficial effects for Physical Functioning, Role Physical, Vitality, Social Functioning as well as for Mental Health were sustained for up to 2 yrs.
Effects of lung volume reduction surgery on lung function and exercise performance
Bilateral thoracoscopic LVRS resulted in significant and clinically relevant improvement of dyspnoea, pulmonary function, and 6MWD (table 1⇓). Shortness of breath was considerably improved after surgery for up to 2 yrs and the mean 6MWD was higher by 68 m as compared to baseline at the end of the study period. The largest improvements in airflow obstruction and pulmonary hyperinflation were observed after 3 months. Thereafter, pulmonary function steadily declined, but remained significantly improved with respect to obstruction to airflow and reduction of hyperinflation for up to 2 yrs.
Correlations between changes in lung function and physical functioning
The SF-36 domain physical functioning assesses the individual's physical function, i.e. the limitation of a person in performing daily physical activities such as bathing or dressing. Since this domain discovered the largest improvement after LVRS, the correlations between changes in pulmonary function and changes in this parameter before and after surgery were investigated. Fair-to-moderate correlations between improvement in lung function and good correlations between changes in timed walking distance, decrease in shortness of breath and improvement in physical functioning were found (table 2⇓, fig. 2⇓)
Discussion
This prospective study in patients suffering from severe pulmonary emphysema showed that LVRS causes major improvements in quality of life lasting for at least 2 yrs, together with relief of dyspnoea, improvement in walking distance and lung function.
The effects of LVRS on pulmonary function were comparable to those reported in the literature 9, 28–31. Recent randomized studies have shown that the degree of improved exercise tolerance in patients with far advanced emphysema achieved by LVRS exceeds that after pulmonary rehabilitation 32, 33. The physiological mechanisms that account for the improvement in lung mechanics, exercise tolerance, and dyspnoea are multifactorial and include increase in lung elastic recoil and expiratory flow 34, decrease in hyperinflation 35, amelioration of respiratory muscle strength 36, 37 and a trend to normalization in breathing pattern 38.
Patients with advanced emphysema primarily suffer from shortness of breath, even during low levels of exercise. This reduces the patient's daily physical activity and has a considerable impact on wellbeing. Therefore, the primary treatment objectives for patients with emphysema are to reduce the degree of dyspnoea occurring at a distinct level of exercise, thereby improving HRQL. While several studies, including those of the present authors, have demonstrated significant improvements of dyspnoea and pulmonary function after LVRS, the purpose of the current investigation was to assess the effects of LVRS on HRQL as well, and to analyse the correlation between changes in functional parameters and alterations in aspects of quality of life.
The SF-36 questionnaire, which consists of 36 questions that cover eight quality of life domains, was selected for assessment of HRQL since it has been widely used and validated in patients with COPD 1 and applied for evaluation of the effect of LVRS 13, 14, 16. In addition, the SF-36 is easy to administer and to analyse. Previous studies have shown variable relationships between lung function and scores for HRQL in patients with COPD, although dyspnoea seems to correlate best with several components of the SF-36 1. Furthermore, it has been shown that disease-specific instruments are not more sensitive for changes than the generic HRQL questionnaires 39.
To the best of the authors' knowledge, three groups have employed the SF-36 to assess the impact of LVRS on HRQL 13, 14, 16. Preoperatively, pulmonary function of these patients was comparable to the cohort studied in this paper, i.e. all had a severe degree of airway obstruction (FEV1 <35% pred) and considerable pulmonary hyperinflation. The various SF-36 categories were reduced by a similar amount in those studies as was observed for the patients in the present study.
Cooper et al. 10 demonstrated significant increases in the SF-36 domains of Physical Functioning, Social Functioning, General Health and Vitality in a cohort of 20 patients, 3 months after bilateral LVRS; and Yusen et al. 13, from the same group, confirmed these findings using a larger study population, 45 patients of whom 17 could be reassessed 1 yr after surgery (table 3⇓). These favourable results were corroborated by Moy et al. 14, who found a similar impact of LVRS on the various SF-36 scores 6 months after LVRS (table 3⇓). In contrast to other groups who evaluated HRQL using alternative instruments 32, neither Yusen et al. 13 nor Moy et al. 14 found significant changes in any of the SF-36 domains after pulmonary rehabilitation alone, which they mandatorily requested before accepting patients for surgery. In a group of 37 patients (functionally somewhat less impaired then those of Yusen et al. 13 and Moy et al. 14) smaller improvements than after LVRS were found in five of the eight quality-of-life subscales of the SF-36 after a 3-week comprehensive pulmonary rehabilitation 40.
The present results corroborate and extend these short-term observations of previous studies by demonstrating significant improvements in several domains of HRQL for at least 2 yrs after LVRS. In accordance with the concept of COPD affecting HRQL predominantly by dyspnoea and impaired physical performance, the domains of Physical Functioning and Role-Physical were those with the most prominent reductions before LVRS and with the most dramatic improvements by surgery. Nevertheless, General Health, Vitality and Social Functioning were also significantly improved. In contrast to other groups 13, 14, 16, the patients in this study did not undergo systematic preoperative pulmonary rehabilitation. Since the degree of improvement in HRQL was comparable to others (table 3⇓) who underwent LVRS after preoperative pulmonary rehabilitation 13, 14, 16, the authors conclude that surgery is the essential component for the achievements of these favourable results.
It was observed, that even without a standardized rehabilitation during this follow-up, important SF-36 domains such as Physical Functioning, Vitality and Social Functioning remained considerably improved for up to 2 yrs. However, it is conceivable that these results could have been further improved by involving the patients in an ongoing rehabilitation programme. It has to be emphasized that pulmonary rehabilitation should not be replaced by LVRS; however, LVRS should be considered in order to treat a minority of patients who remain severely symptomatic despite best medical treatment and fulfilling the empirically elaborated criteria for a successful functional outcome after surgery 10, 41.
HRQL after LVRS has also been assessed by other instruments, such as the Nottingham Health Profile 10, 13, the Sickness Impact Profile 12, 18, 32, 42, the Chronic Respiratory Disease Questionnaire 15 and the St. George's respiratory Questionnaire 17. In general, positive effects were found. However, these data are not directly comparable to the results found in the present study and other studies using the SF-36. Nevertheless, these investigations confirm that LVRS not only improves dyspnoea, pulmonary function and exercise tolerance, but has a favourable impact on various HRQL dimensions.
The authors acknowledge that incomplete follow-up may have biased the present findings, since patients who were satisfied with the results of LVRS are more likely to return for follow-up examinations. However, comparison of preoperative and 3 months postoperative data among patients available for the current analysis and those lost for follow-up does not reveal relevant differences with regard to pulmonary function and dyspnoea. This suggests that the potential bias is less than suspected.
Until now, no long-term data on the natural history of HRQL in COPD patients, who suffer from a disease severity comparable with those undergoing LVRS have been available. Some limited information can be derived from the publication of Geddes et al. 33. These authors found significant improvements in a SF-36 summary score at 6 and 12 months in the LVRS group as compared to the rehabilitation group, where quality of life tended to deteriorate over time. However, these authors used a HRQL summary score, the calculation of which is not described in the method section of their publication. In a few years, information regarding the natural history of HRQL in COPD patients under best medical care will be available from the National Emphysema Treatment Trial study, where patients are randomly assigned to conservative treatment or LVRS 43. From all the available evidence, the natural history of the health status decline is most likely to be less pronounced after LVRS, as it is in a comparably severe emphysema population.
In conclusion, the present authors were able to demonstrate a major long-term benefit from lung volume reduction surgery on health-related quality of life in patients with advanced emphysema exceeding the improvement expected from any nonsurgical therapy.
Change and time course of health-related quality of life domains (Short Form 36-item questionnaire) after lung volume reduction surgery for up to 2 yrs. PF: Physical Functioning (76); RP: Role-Physical (74); VT: Vitality (60); GH: General Health (64); SF: Social Functioning (81); RE: Role-Emotional (80); MH: Mental Health (75); BP: Bodily Pain (67) (numbers in brackets: scores for a healthy, sex-matched population of the same age). •: healthy populations; ○: preoperative; □: 3 months; ⋄: 12 months; ▵: 24 months. *: p<0.05, compared to baseline.
Relationship between the change in a) hyperinflation (r=−0.55, p=0.001) and b) 6-min walking distance (6MWD) (r=0.69, p≤0.001) and physical functioning 2 yrs after lung volume reduction surgery. RV: residual volume; TLC: total lung capacity.
Health related quality of life, dyspnoea and lung function before and up to 2 yrs after lung volume reduction surgery
Correlations between Changes in Pulmonary Function and health-related quality of life Dimension
Comparison of Short Form 36-item questionnaire scores and pulmonary function in present study with previously published values before and after lung volume reduction surgery
Appendix: the eight health components captured by the Short Form-36
1) Physical Functioning: assesses the individual's physical function. Low scores mean that the individual is limited severely in performing all physical activities including bathing or dressing, due to health.
2) Role-Physical: assesses the potential of physical activity. Low scores mean that the individual has problems with work or other daily activities as a result of physical health.
3) Bodily Pain: assesses physical wellbeing and its consequences on physical activity. Low scores mean that bodily pain is very severe and extremely limiting.
4) General Health: evaluates the personal evaluation of physical and mental health. A low score not only means that the individual evaluates their personal health as poor, but also believes that it is likely to get worse.
5) Vitality: assesses physical and mental wellbeing. Whereas a high score means that the individual feels full of pep and energy all of the time, a low score means that the individual feels tired and worn out all of the time.
6) Social Functioning: assesses the limitation of social participation due to physical and mental disability. Low scores mean an extreme and frequent interference with normal social activities due to physical or emotional problems, whereas high scores mean that the individual performs normal social activities without interference due to physical or emotional problems.
7) Role-Emotional: assesses mental disability. A low score means that the individual has problems with work or other daily activities as a result of emotional problems.
8) Mental Health: assesses mental function and wellbeing. A low score means that an individual feels nervous and depressed all of the time.
- Received August 24, 2001.
- Accepted September 2, 2001.
- © ERS Journals Ltd